SCHEMBL75265

SCHEMBL75265

c1cc2c(s1)CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2485508 0.97 PNMT (0.48)
SCHEMBL15281530 0.97 PNMT (0.48)
SCHEMBL15276726 0.97 PNMT (0.48)
SCHEMBL15278765 0.97 PNMT (0.48)
SCHEMBL828997 0.94
Oxalic Acid SCHEMBL4777724 0.87 ALDH1A1 (0.44)
SCHEMBL562638 0.82
SCHEMBL19135901 0.79 DRD2 (0.42)
SCHEMBL19674177 0.79 PNMT (0.38)
SCHEMBL19135935 0.77 PNMT (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3446 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250296926-A1 SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2025-09-25 US claimed
US-12351574-B2 Selective ligands for modulation of GIRK channels NORTHEASTERN UNIVERSITY (US) 2025-07-08 US claimed
CN-120021621-A Application of 4,5,6, 7-tetrahydrobenzothiophene compounds in pest control 中国农业大学 2025-05-23 CN claimed
WO-2025101127-A1 CONJUGATED OLIGOELECTROLYTES AND METHODS STAINING MITOCHONDRIA THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2025-05-15 WO claimed
US-20240199591-A1 SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2024-06-20 US claimed
US-11952370-B2 Selective ligands for modulation of GIRK channels NORTHEASTERN UNIVERSITY (US) 2024-04-09 US claimed
EP-4008717-A2 NOVEL INHIBITORS OF INSULIN-LIKE GROWTH FACTOR 2 MRNA BINDING PROTEINS Martin-Luther-Universität Halle-Wittenberg (DE) 2022-06-08 EP claimed
EP-4008716-A1 NOVEL INHIBITORS OF INSULIN-LIKE GROWTH FACTOR 2 MRNA BINDING PROTEINS Martin-Luther-Universität Halle-Wittenberg (DE) 2022-06-08 EP claimed
US-20210253561-A1 SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS NORTHEASTERN UNIVERSITY 2021-08-19 US claimed
CN-113260609-A Aromatic receptor antagonists and methods of use thereof 美真达治疗公司 2021-08-13 CN claimed
US-20040116439-A1 Serine protease inhibitors TULARIK LIMITED (GB) 2004-06-17 US claimed
EP-1420784-A1 COMPOUNDS EFFECTING GLUCOKINASE Astrazeneca AB (SE) 2004-05-26 EP claimed
US-20030216403-A1 Serine protease inhibitors TULARIK LIMITED (GB) 2003-11-20 US claimed
US-20030203909-A1 Fused bicyclic amide compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-10-30 US claimed
EP-1310488-A1 FUSED BICYCLIC AMIDE COMPOUNDS AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-05-14 EP claimed
EP-1294691-A1 SERINE PROTEASE INHIBITORS Tularik Limited (GB) 2003-03-26 EP claimed
WO-2003015774-A1 COMPOUNDS EFFECTING GLUCOKINASE ASTRAZENECA AB (SE) 2003-02-27 WO claimed
WO-2001096305-A1 SERINE PROTEASE INHIBITORS TULARIK LIMITED (GB) 2001-12-20 WO claimed
EP-0381422-B1 Tetrahydrobenzimidazole derivatives YAMANOUCHI PHARMA CO LTD (JP) 1996-10-23 EP claimed
US-5344927-A 5-HT3 antagonist YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-09-06 US claimed